Â鶹ŮÓÅ

Scientists at the National Institutes of Health have been told the communications pause announced by the Trump Administration earlier this week includes a pause on all purchasing, including supplies for their ongoing studies, according to four sources inside the agency with knowledge of the purchasing hold. (Goodman and Tirrell, 1/24)

An article that was written by U.S. Department of Health and Human Services employees and slated for publication in a medical journal this spring was placed on hold last week, apparently as a result of the Trump administration freeze on communications from government agencies. (Silverman, 1/26)

The Food and Drug Administration has removed webpages about diversity and inclusion in clinical trials for cancer drugs. The page for Project Equity, a 2021 initiative launched by the FDA's Oncology Center of Excellence to ensure that cancer drugs were evaluated for approval based on data from a diverse group of study participants, has gone dark. (Lupkin, 1/25)

Medical and biomedical researchers across North Carolina are used to pondering some of the most vexing questions in health and biology, but a directive issued last week by President Donald Trump left many without answers when it came to the future of their life-saving and life-enhancing research projects. (Hoban, 1/27)